(Q34693555)

4 August 2017

1 reference

title

Glipizide: a review of its pharmacological properties and therapeutic use. (English)

1 reference

4 August 2017

1 reference

ChEBI release 2020-05-28

1

Brogden RN

1 reference

4 August 2017

Heel RC

2

1 reference

4 August 2017

Pakes GE

series ordinal

3

1 reference

4 August 2017

Speight TM

series ordinal

4

1 reference

4 August 2017

Avery GS

series ordinal

5

1 reference

4 August 2017

1 November 1979

1 reference

4 August 2017

1 reference

4 August 2017

18

1 reference

4 August 2017

5

1 reference

4 August 2017

329-353

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-197918050-00001

4 August 2017

0 references

cites work

Effect of glipizide on the release of insulin in the perfused rat pancreas in vitro

1 reference

12 December 2020

Pharmacodynamic aspects of two sulphonylurea derivatives glipizide and glibenclamide.

1 reference

12 December 2020

Glipizide--a new oral antidiabetic

1 reference

12 December 2020

Diazoxide, glipizide, hypertension and hypoglycaemia

1 reference

12 December 2020

[Changes in insulin (IRI) and NEFA levels in diabetic subjects after acute intravenous glipizide and tolbutamide administration]

1 reference

12 December 2020

Clinical study with glipizide, a new oral antidiabetic drug

1 reference

12 December 2020

Clinical and metabolic observations with a new synthetic oral antidiabetic agent, glipizide.

1 reference

12 December 2020

Diazoxide, glipizide, and hypoglycaemia

1 reference

12 December 2020

[Evaluation of a new sulfonylurea, glipizide, in the treatment of diabetes mellitus]

1 reference

12 December 2020

[Clinical experimentation with a new hypoglycemic agent (glipizide)]

1 reference

12 December 2020

Glipizide versus tolbutamide in maturity-onset diabetes, an open comparative study

1 reference

12 December 2020

Effects of Glipizide and Food Intake on the Blood Levels of Glucose and Insulin in Diabetic Patients

1 reference

12 December 2020

Clinical experience with glipizide in the treatment of mostly complicated diabetes

1 reference

12 December 2020

Glipizide in the treatment of maturity-onset diabetes: a multi-centre, out-patient study

1 reference

12 December 2020

Clinical evaluation of glipizide. Results of a multicentric study in Spain

1 reference

12 December 2020

Dynamics of sulfonylurea-induced insulin release from the isolated perfused rat pancreas

1 reference

12 December 2020

An open comparative study of the efficacy and tolerance of a new antidiabetic agent: glipizide.

1 reference

12 December 2020

Glipizide, a new oral antidiabetic agent (report of a controlled clinical study in Sweden)

1 reference

12 December 2020

Sulphonylureas increase the number of insulin receptors

1 reference

12 December 2020

Clinical trial with glipizide in uncomplicated maturity onset diabetes mellitus

1 reference

12 December 2020

Modifications of glycemia and insulinemia in diabetics treated with glipizide (K 4024), a new sulfonylurea

1 reference

12 December 2020

Comparison of the pharmacokinetics of glipizide and glibenclamide in man

1 reference

12 December 2020

New oral hypoglycemic agent: K 4024 or glipizide. Clinical trial

1 reference

12 December 2020

[Experimental study of glipizide. A comparison with other hypoglycemic sulfonamides (author's transl)]

1 reference

12 December 2020

Metabolism and Kinetics of the Hypoglycemic Agent Glipizide in Man—Comparison with Glibenclamide

1 reference

12 December 2020

Glipizide, a new sulfonylurea in the treatment of diabetes mellitus. Summary of clinical experience in 1064 cases.

1 reference

12 December 2020

A controlled clinical trial of a new oral hypoglycemic agent, glipizide (K 4024)

1 reference

12 December 2020

Clinical experience concerning the action of a new oral antidiabetic drug: glidiazinamide

1 reference

12 December 2020

Interactions of sulfonylureas with plasma proteins.

1 reference

12 December 2020

[Clinical trial of a new oral antidiabetic: glypizide]

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics as well as metabolism following orally and intravenously administered C14-glipizide, a new antidiabetic

1 reference

12 December 2020

Metabolites of hypoglycemic sulfonylureas in kidney failure. Experience with glibenclamide

1 reference

12 December 2020

A controlled study of the hypoglycemic and insulinopoietic effect of glipizide and glibenclamide in non-diabetic human subjects

1 reference

12 December 2020

Comparative study of the hypoglycaemic and antilipolytic effects of four antidiabetic agents administered i.v

1 reference

12 December 2020

[Hypoglycemic effect of glipizide. Study in 20 diabetic patients with low pancreatic insulin reserve]

1 reference

12 December 2020

Effect of glipizide on a double-meal test in diabetic patients.

1 reference

12 December 2020

Glipizide-phenformin combination in the treatment of diabetes mellitus

1 reference

12 December 2020

Metabolism of glipizide in the rat and dog and its tissue distribution in the mouse

1 reference

12 December 2020

Interaction of glipizide with human serum albumin

1 reference

12 December 2020

Potentiation of insulin action: a probable mechanism for the anti-diabetic action of sulfonylurea drugs

1 reference

12 December 2020

Pharmacokinetics and metabolism of N-(4-( -(5-methylpyrazine-2-carboxyamido)-ethyl)-benzensulfonyl)-N'cyclohexylurea (K 4024) in experimental animals and in man

1 reference

12 December 2020

Pharmacokinetics of glipizide in man: Influence of renal insufficiency

1 reference

12 December 2020

Clinical evaluation of a new sulfonylurea in maturity onset diabetes - glipizide (K-4024)

1 reference

12 December 2020

Clinical trial of glypizide

1 reference

12 December 2020

Glipizide (‘Glibenese’) in maturity-onset diabetes mellitus

1 reference

12 December 2020

10.2165/00003495-197918050-00001

Identifiers

DOI

1 reference

Dimensions Publication ID

4 August 2017

0 references

1 reference